Skip to main content

Ischemic Stroke and Transient Ischemic Attack – Acute Evaluation and Management

  • Chapter
  • First Online:
Stroke Essentials for Primary Care

Part of the book series: Current Clinical Practice ((CCP))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 139.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 109.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Lyden PD, Ischemic penumbra and neuronal salvage. In: Lyden, PD Thrombolytic Therapy for Stroke, Totowa: Humana Press, 2001:44.

    Chapter  Google Scholar 

  2. Biller J, Ischemic cerebrovascular disease, In: Biller J, ed. Practical Neurology, 2nd ed., Philadelphia: Lipincott Williams & Wilkins, 2002:445.

    Google Scholar 

  3. Feldmann E et al., Factors associated with early presentation of acute stroke. Stroke. 1993; 24:1805–1810.

    Article  PubMed  CAS  Google Scholar 

  4. Alberts MJ et al., Effects of public and professional education on reducing the delay in presentation and referral of stroke patients. Stroke. 1992;23:352–356.

    Article  PubMed  CAS  Google Scholar 

  5. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med. 1995; 333: 1581–1587.

    Article  Google Scholar 

  6. Katzan IL et al. Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience, JAMA. 2000 Mar 1;283(9):1151–8.

    Google Scholar 

  7. Katzan IL et al. Quality improvement and tissue-type plasminogen activator for acute ischemic stroke: a Cleveland update. Stroke. 2003 Mar;34(3):799–800.

    Google Scholar 

  8. Adams, HP et al. Guidelines for the Early Management of Adults With Ischemic Stroke. Stroke. 2007; 1655–1711.

    Google Scholar 

  9. Furlan, A. et al. Intra-arterial Prorokinase for Acute Ischemic Stroke. JAMA. 1999;282:2003–2011.

    Article  PubMed  CAS  Google Scholar 

  10. del Zoppo GJ et al.: PROACT: a phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke. 1998;29:4–11.

    Article  PubMed  CAS  Google Scholar 

  11. Smith WS et al. Safety and efficacy of mechanical embolectomy in acute ischemic stroke-results of the MERCI trial. Stroke. 2005; 36: 1432–1438.

    Article  PubMed  Google Scholar 

  12. Weir CJ et al. Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long-term follow up study. BMJ. 1997; 314: 1303–1306.

    Article  PubMed  CAS  Google Scholar 

  13. Leigh R et al. Predictors of hyperacute clinical worsening in ischemic stroke patients receiving thrombolytic therapy. Stroke. 2004; 35: 1903–1907.

    Article  PubMed  CAS  Google Scholar 

  14. Adams, HP et al. Guidelines for the early management of adults with ischemic stroke. Stroke. 2007; 1655–1711.

    Google Scholar 

  15. Kennedy, J. et al. Fast assessment of stroke and transient ischaemic attack to prevent early recurrence (FASTER): a randomised controlled pilot trial. Lancet Neurol. 2007 Nov;6(11):961–9.

    Google Scholar 

  16. Diener HC et al. Aspirin and clopidogrel compared with clopidogrel alone after recent ischaemic stroke or transient ischaemic attack in high-risk patients (MATCH): randomised, double-blind, placebo-controlled trial. Lancet. 2004 Jul 24–30;364(9431):331–7.

    Article  PubMed  CAS  Google Scholar 

  17. Sherman DG, et al. “The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison” Lancet. 2007; 369: 1347–1355.

    Article  PubMed  CAS  Google Scholar 

  18. Kamphuisen et al. Prevention of venous thromboembolism after acute ischemic stroke. J Thromb Haemost. 2005 36;1187–1194.

    Google Scholar 

  19. Reith J et al. Body temperature in acute stroke: relation to stroke severity, infarct size, mortality, and outcome. Lancet. 1996; 347: 422–425.

    Article  PubMed  CAS  Google Scholar 

  20. Kammersgaard LP, Jorgensen HS, Rungby JA, Reith J, Nakayama H, Weber UJ, Houth J, Olsen TS. Admission body temperature predicts long-term mortality after acute stroke: the Copenhagen Stroke Study. Stroke. 2002; 33: 1759–1762.

    Article  PubMed  CAS  Google Scholar 

  21. Vahedi K, Hofmeijer J, Juettler E, Vicaut E , George B, Algra A, Amelink GJ, Schmiedeck P, Schwab S, Rothwell PM, Bousser MG, van der Worp HB, Hacke W. Early decompressive surgery in malignant infarction of the middle cerebral artery: a pooled analysis of three randomised controlled trials. Lancet Neurol. 2007 Mar;6(3):215–22.

    Google Scholar 

  22. Johnston, SC et al. Short-term prognosis after emergency department diagnosis of TIA. JAMA. 2000; 284:2901–2906.

    Article  PubMed  CAS  Google Scholar 

  23. Lavallee, PC et al. A Transient Ischaemic Attack Clinic With Round-the-Clock Access (SOS-TIA): Feasibility and Effects Lancet Neurol. 2007; 6 (November): 953–960.

    Article  PubMed  CAS  Google Scholar 

  24. Rothwell, PM et al. Effect of Urgent Treatment of Transient Ischaemic Attack and Minor Stroke on Early Recurrent Stroke (EXPRESS Study): A Prospective Population-Based Sequential Comparison. Lancet. 2007; 370 (October 20): 1432–1442.

    Article  PubMed  Google Scholar 

  25. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients: the Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000; 342: 145–153.

    Article  PubMed  CAS  Google Scholar 

  26. Lawes CMM, Bennett DA, Feigin VL, Rodgers A. Blood pressure and stroke: an overview of published reviews. Stroke. 2004; 35: 776–785.

    Article  PubMed  Google Scholar 

  27. Halperin JL Anticoagulation for atrial fibrillation in the elderly. Am J Geriatr Cardiol. 2005 Mar-Apr;14(2):81–6.

    Article  PubMed  Google Scholar 

  28. Ferguson et al. The North American Symptomatic Carotid Endarterectomy Trial (NASCET). Stroke. 1999;30:1751–1758.

    Google Scholar 

  29. UK-TIA Study Group. United Kingdom transient ischaemic attack (UK-TIA) aspirin trial: Interim results. Br Med J. 1988;296:316–320.

    Article  Google Scholar 

  30. The Dutch TIA Study Group. Protective effects of low-dose aspirin and atenolol in patients with transient ischemic attacks or nondisabling stroke: the Dutch TIA Trial. Stroke. 1988; 19: 512–517.

    Article  Google Scholar 

  31. CAPRIE Steering Committee. A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet. 1996 Nov 16;348(9038):1329–39.

    Article  Google Scholar 

  32. Diener HC, Cunha L, Forbes C, Sivenius J, Smets P, Lowenthal A. European Stroke Prevention Study, 2: dipyridamole and acetylsalicylic acid in the secondary prevention of stroke. J Neurol Sci. 1996; 143: 1–13.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2009 Humana Press, a part of Springer Science+Business Media, LLC

About this chapter

Cite this chapter

McElveen, W.A., Alway, D. (2009). Ischemic Stroke and Transient Ischemic Attack – Acute Evaluation and Management. In: Alway, D., Cole, J.W. (eds) Stroke Essentials for Primary Care. Current Clinical Practice. Humana Press. https://doi.org/10.1007/978-1-59745-433-9_2

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-433-9_2

  • Published:

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-934115-01-5

  • Online ISBN: 978-1-59745-433-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics